Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000363080 | SCV000342456 | uncertain significance | not provided | 2017-10-20 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000765499 | SCV000896800 | uncertain significance | Joubert syndrome with renal defect; Nephronophthisis 1; Senior-Loken syndrome 1 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001084490 | SCV001000789 | likely benign | Nephronophthisis | 2025-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000363080 | SCV001875174 | uncertain significance | not provided | 2025-01-20 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Prevention |
RCV004535410 | SCV004730665 | likely benign | NPHP1-related disorder | 2022-02-03 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Institute of Human Genetics, |
RCV004816513 | SCV005070247 | uncertain significance | Retinal dystrophy | 2023-01-01 | no assertion criteria provided | clinical testing |